Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 347.5 JPY -1.24% Market Closed
Market Cap: 554.4B JPY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is 2 904.96 JPY. Compared to the current market price of 2 347.5 JPY, Rohto Pharmaceutical Co Ltd is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
2 904.96 JPY
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
85
vs Industry
27
Median 3Y
2.8
Median 5Y
2.6
Industry
1
Forward
1.7
More Details
18.1
P/E
P/E
Price to Earnings
18.1
vs History
90
vs Industry
30
Median 3Y
25.2
Median 5Y
25.2
Industry
16.4
Forward
16.2
More Details
13.6
P/OCF
P/OCF
Price to OCF
13.6
vs History
95
vs Industry
31
Median 3Y
22.6
Median 5Y
20.9
Industry
11.5
More Details
9.6
P/FCFE
P/FCFE
Price to FCFE
9.6
vs History
95
vs Industry
39
Median 3Y
35.8
Median 5Y
32.1
Industry
17.6
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
88
vs Industry
30
Median 3Y
3
Median 5Y
2.9
Industry
1.5
More Details
1.7
EV/S
EV/S
Enterprise Value to Sales
1.7
vs History
79
vs Industry
32
Median 3Y
2.5
Median 5Y
2.3
Industry
1.1
Forward
1.6
More Details
2.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.9
vs History
73
vs Industry
54
Median 3Y
4.4
Median 5Y
4
Industry
3.7
More Details
10.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.7
vs History
77
vs Industry
33
Median 3Y
14.4
Median 5Y
12.8
Industry
9.6
Forward
9.1
More Details
13.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.3
vs History
84
vs Industry
32
Median 3Y
17.5
Median 5Y
15.7
Industry
12.5
More Details
12.5
EV/OCF
EV/OCF
Enterprise Value to OCF
12.5
vs History
95
vs Industry
34
Median 3Y
20.7
Median 5Y
18.7
Industry
11.9
More Details
16.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
16.7
vs History
95
vs Industry
27
Median 3Y
30.1
Median 5Y
29.6
Industry
15.1
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
95
vs Industry
33
Median 3Y
2.6
Median 5Y
2.3
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Rohto Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Rohto Pharmaceutical Co Ltd
TSE:4527
535.6B JPY 1.8 18.1 10.7 13.3
FR
L'Oreal SA
PAR:OR
199.9B EUR 4.6 31.2 19.2 23.3
UK
Unilever PLC
LSE:ULVR
116.1B GBP 2.2 23.7 146.6 169.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.7 51.5 36.1 39.7
UK
HALEON PLC
LSE:HLN
34.2B GBP 3 23.7 14.1 15.9
DE
Beiersdorf AG
XETRA:BEI
26.8B EUR 2.7 29.3 12.4 15.1
US
Estee Lauder Companies Inc
NYSE:EL
21.4B USD 1.4 -30.5 11.3 17.6
JP
Kao Corp
TSE:4452
2.8T JPY 1.7 26.1 11.2 18
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9.2 -286.1 42.2 45.3
CN
Giant Biogene Holding Co Ltd
HKEX:2367
79.3B HKD 13.4 36.1 27.9 28.4
IN
Dabur India Ltd
NSE:DABUR
858.9B INR 6.8 47.8 35.8 43.7
P/E Multiple
Earnings Growth PEG
JP
Rohto Pharmaceutical Co Ltd
TSE:4527
Average P/E: 31.9
18.1
8%
2.3
FR
L'Oreal SA
PAR:OR
31.2
9%
3.5
UK
Unilever PLC
LSE:ULVR
23.7
14%
1.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51.5
9%
5.7
UK
HALEON PLC
LSE:HLN
23.7
13%
1.8
DE
Beiersdorf AG
XETRA:BEI
29.3
12%
2.4
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -30.5
43%
N/A
JP
Kao Corp
TSE:4452
26.1
10%
2.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -286.1 N/A N/A
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
36.1
25%
1.4
IN
Dabur India Ltd
NSE:DABUR
47.8
9%
5.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.